Massachusetts Institute of Technology researcher and Alnylam Pharmaceuticals co-founder Phillip Sharp has been named chair of the Cancer Prevention and Research Institute of Texas' scientific review council, which oversees the selection of the agency's research grants.
CPRIT was established in 2007 to issue $3 billion over 10 years to fund grants for cancer research and prevention.
Opko Health has named Jamie Freedman as vice president of research and development and business development.
Freedman was previously CEO of Locus Pharmaceuticals. Before that, he held various positions at Merck Research Labs. He has an MD and PhD from Tufts University.